Alexandre Fort
About Alexandre Fort
Title: Lead Scientist, Genomics
Alexandre Fort holds the position of Lead Scientist in the field of Genomics. With a dedicated focus on genomics research, Fort is involved in leading and conducting advanced studies and experiments, contributing significantly to the understanding and advancement of genomic science.
Education and Expertise in Genomics
Alexandre Fort holds a PhD, specializing in genomics. His expertise encompasses a wide range of topics within the field, including immunologic factors in cancer treatment, cell-free DNA characterization, and spatial transcriptomics. Fort's academic background and extensive research have established him as a knowledgeable figure in the genomics community.
Published Research on Cancer Treatment
Alexandre Fort has published research focused on immunologic factors associated with differential responses to neoadjuvant chemoimmunotherapy in triple-negative breast cancer. His work contributes valuable insights into how immunologic factors can influence treatment outcomes, aiding in the development of more effective cancer therapies.
Presented Research on Genomic Profiling and Immunoassays
Fort has presented posters on several advanced topics within genomics. His presentations include NK cell ADCC assays, comprehensive genomic profiling for hematologic malignancies, and studies on TIGIT and PD-L1 co-expression in solid tumors. These contributions highlight his involvement in cutting-edge research and his role in disseminating new knowledge in the field.
Research on Liquid Biopsy and Tumor Microenvironment
Alexandre Fort has conducted significant research on the pre-analytical characterization of cell-free DNA for liquid biopsy in solid tumors. He has also worked on the analytical performance of contrived samples for the validation of liquid biopsy assays and the enhanced detection of ctDNA molecular response for immunotherapy-treated non-small cell lung cancer. Additionally, Fort's research on spatial transcriptomic studies of the tumor microenvironment in head and neck squamous cell carcinoma (HNSCC) contributes to a deeper understanding of tumor biology and how it can be targeted in cancer treatments.